Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EOS Imaging SA Announces FDA Approval for 3D Imaginig for Post-operative Hip Implant Assessment


Tuesday, 19 Mar 2013 03:30am EDT 

EOS Imaging SA announced that its sterEOS 3D imaging software, sterEOS 1.5, has received 510(k) clearance from the United States Food and Drug Administration (FDA). The sterEOS software provides three-dimensional (3D) modeling of the spine and lower limb based on scans taken with the EOS System, and automatically calculates over 100 clinical parameters relevant to diagnosis and surgical planning. The new sterEOS 1.5 offers expanded calculation and analysis, with new capabilities to measure hip implant component position for surgery control and revision. Other key features include 3D modeling of severe scoliosis (Cobb angle above 50°). sterEOS 1.5, is expected to be made available to existing EOS Imaging SA customers as a software upgrade and will be included in all new system sales. 

Company Quote

5.14
0.01 +0.19%
11:35am EST